GHRP-2 dosage and evidence
Written by Aaron CuhaReviewed Sep 2026
The short answer
GHRP-2 is a lab-made peptide that makes the body release a strong burst of growth hormone. Japan approves it as a test for growth hormone shortage. It pushes appetite less than GHRP-6, but it still pushes it.
Evidence grade for GHRP-2: Moderate. The rule: at least one finished study in people, and at least 100 people who took it. The sum on this page: 3 completed trials, 102 people given it. A grade counts how much has been done to people, not whether it works.
- People given it
- 102
- Human studies
- 3
- Found nothing
- 2
Dose
No human dose established
Amounts that circulate in forums and on vendor pages are not a human dose. Amounts that were given in studies sit in Human evidence on this page.
Commonly reported amounts, in mcg. No approved label.
Amounts commonly reported by people buying GHRP-2, recorded for this archive's reconstitution calculator, are 100, 200 and 300 mcg. They are self-reports rather than trial doses, and this archive does not recommend any of them. No US approval sets a dose for GHRP-2, and GHRP-2 is approved in Japan, where its label carries one. These reported amounts are not that label's dose.
| Reported amount | Where the number comes from |
|---|---|
| 100 mcg | Commonly reported, no published human dosing trial |
| 200 mcg | Commonly reported, no published human dosing trial |
| 300 mcg | Commonly reported, no published human dosing trial |
7 effects reported, 4 unwanted, 3 wanted, by people using it, not a trial
Goal pages: Fat loss and metabolism, Hormones and growth hormone
In plain English
In plain English, from Aaron
This is how I would explain it to a friend. The evidence, with the numbers, is further down the page.
GHRP-2 makes your body put out a burst of growth hormone. It is an older shot from the same family as GHRP-6 and hexarelin. People stack it with CJC-1295. In Japan it is approved as a test, to check if the gland in your head can still make growth hormone. It is not approved as a treatment anywhere. The US work on it as a drug was dropped.
What people take it for
- More growth hormone without taking growth hormone itself.
- Muscle, fat loss and better sleep from the growth hormone bump.
- A milder hunger hit than GHRP-6, so they can run it without eating the house.
- Stacking it with CJC-1295 for a bigger release.
What studies in people showed
The best human data is a test, not a treatment. Doctors gave a 100 microgram shot into a vein to 77 healthy people and 58 people who lacked growth hormone. A peak under 15 micrograms per litre picked out the people with a severe lack of it. That is what it is approved for in Japan. It also makes you hungry. Seven lean men got it by drip and ate about 36 percent more. So the hunger is less than GHRP-6, not gone. There is no trial on this page of it building muscle or burning fat. Nobody has tested that here.
What people report
Reports, not study results
The good
- Hunger, but much less than GHRP-6. Most people call it manageable.
- Deeper sleep and vivid dreams when taken before bed.
- Fuller looking muscles from water, which some people like.
The bad
- Hunger still hits within about half an hour for a lot of people.
- Water retention and puffy hands or face.
- Tingling or numb hands, and a tired, heavy feeling after the shot.
- Forum side effect guides say it raises cortisol and prolactin. This page has no trial that measured that for GHRP-2, so treat it as a report.
Where these come from: The 36 percent hunger number and the test numbers are from the trials on this page. The sleep, water, tingling and cortisol reports are from r/Peptides and peptide vendor side effect guides. Vendor guides are not neutral and none of it is from a trial.
My bottom line
This is a test drug that got repurposed. The Japan approval is for a diagnosis, not for your biceps. I would not build a muscle plan on a shot with no muscle trial behind it.
An opinion, not a finding. I am a coach, not a doctor.
What it has been measured to do
Measured in people
Goals GHRP-2 has been tested for in people, biggest studies first. We count only what the studies on this page say, so the real numbers may be higher.
- Growth hormone and IGF-115 people · 1 study · 1 found nothing
- Feeling less hungry17 people · 2 studies · 1 found nothing
What people using it report
Real people telling you what happened to them. Nobody checked it, and the people who post are not a fair sample, so it cannot prove anything works. It is still the best guide on this page to what people actually do with GHRP-2, what they expect, and what goes wrong. The full account, including the negative reports, is below.
33 of the 36 indexed goals have no study of any kind behind GHRP-2
No study in people, animals or cells on this page reports a result for these. That does not prove GHRP-2 does nothing for them. It does mean anything you have heard about GHRP-2 and one of these did not come from a study cited here.
Show full evidence
What is GHRP-2?
GHRP-2 is a lab-made peptide that makes the body release a strong burst of growth hormone. Japan approves it as a test for growth hormone shortage. It pushes appetite less than GHRP-6, but it still pushes it.
GHRP-2, also called pralmorelin, is a lab-made peptide that makes the pituitary gland release growth hormone. Japan approves it as a test to check whether the pituitary makes enough growth hormone. Work to make it a US treatment was stopped. The test was checked in 77 healthy people and 58 people short of growth hormone. One 100 microgram shot into a vein, with a cutoff of 15 micrograms per litre at the peak, reliably picked out adults with severe growth hormone shortage. It still raises appetite. In seven lean men, a drip of it made them eat about 36% more. Outside the Japanese test approval, it is not an approved treatment in the US, UK, Australia or Canada.
How does GHRP-2 work?
It switches on the ghrelin receptor, which makes the pituitary gland release a strong burst of growth hormone.
What have studies in people found about GHRP-2?
GHRP-2 is approved in Japan as a one-dose test for growth hormone problems, and that is where the solid human data sit. The treatment data are two studies with no comparison group, in 25 children with poor growth in total, plus single-drip studies in healthy adults. No trial has tested it in healthy adults for body make-up or performance.
- The test (already cited on this page): 77 healthy people and 58 patients with growth hormone deficiency got a 100 microgram dose into a vein. A growth hormone peak of 15 micrograms/L was used as the cut-off.
- Nasal spray in children: 15 short children, half of them growth hormone deficient, took 5 to 15 micrograms/kg up the nose twice a day for 3 months, then three times a day. Their growth rate rose from 3.7 to 6.1 cm a year at 6 months. The 6 children followed for 18 to 24 months were growing 6.0 cm a year. A growth hormone carrier protein in the blood rose from 439 to 688 pmol/L. IGF-1 and a related protein did not change much, and neither did the growth hormone response to a dose. There was no comparison group.
- Pills in children: 10 young children with growth hormone deficiency swallowed 900 micrograms/kg twice a day for 12 months. 7 of 10 reported a big rise in appetite in the first 6 months. Their weight-for-height score went from 0.21 to 0.25, which the authors say was too small to mean anything. There was no comparison group.
- Appetite in healthy men (already cited): in 7 lean men, a GHRP-2 drip raised how much they chose to eat by about 36%, alongside a strong growth hormone rise.
- The detail worth keeping from the nasal spray study: growth hormone was released and growth sped up, but IGF-1 did not change much. IGF-1 is the blood marker usually treated as proof of a tissue-building growth hormone effect.
What this does not tell you: The two treatment studies had no comparison group, were in children with poor growth, and had 25 people in total. The healthy adult data are single drips measuring growth hormone and food intake over a few hours. Nothing has measured muscle, fat, strength, sleep or recovery in an adult. Nothing covers months or years of self-injection under the skin. The Japanese approval shows that one 100 microgram dose into a vein is safe enough for a test. That says nothing about repeated doses. And a test only needs the peptide to release growth hormone on cue, nothing more.
What do people who took GHRP-2 report?
This is what real people say happened to them, good and bad. Nobody measured it. A report cannot tell a real effect from the lift people get just from expecting it to work, from a diet or training change made at the same time, or from what was really in the vial. We still put it near the top. It is the next best thing to a study in people: what happens when real people use it, including what goes wrong.
- Almost never used alone. The standard pattern described is pairing it with a lab made copy of the brain's growth hormone release signal, usually modified GRF 1-29, which means essentially no self-report isolates it. Premixed combination vials are widely distrusted and separate vials are the preference.
- Doses described cluster around 100 to 300 mcg per injection, once to three times a day, with a long-running argument that smaller amounts do little and a counter-position that multiple small doses are preferable to one large one. People describe strict fasting rules around injections, waiting hours after food and delaying eating afterwards.
- The most consistent immediate report is warm facial flushing within minutes of injecting, lasting roughly half an hour, and its absence is treated by users as a sign the vial is not what it claims rather than as a personal difference.
- Sleep is described as disrupted in the first weeks, difficulty falling asleep and waking in the night, then settling and becoming the effect people most often say they value. Body composition changes are described over months rather than weeks and almost always alongside training and testosterone therapy, which posters usually say themselves.
- The clearest negative is carpal tunnel type symptoms, night cramping, arm pain and numbness from the elbow down, described as dose related and as resolving on stopping. Lightheadedness and a low blood sugar feeling that does not match measured glucose also recur, along with swelling and water retention. Compared with GHRP-6 it is described as raising hunger less, and compared with ipamorelin as raising cortisol and prolactin more.
- Results are widely described as modest and gradual, with experienced posters pushing back on expectations of visible transformation, and batch to batch inconsistency between vendors is blamed whenever nothing happens.
- Cost relative to growth hormone itself is a recurring reason people choose it, and the cost of the extra drugs people take to manage cortisol and prolactin is raised as an argument against that framing.
Sources: Threads on ExcelMale and Bluelight, found by site-restricted search and read directly, September 2026. Nothing above is attributed to any specific post and no post is reproduced.
The state of the research
GHRP-2 is the one compound in this group that a company did own and took all the way to approval. The kind of approval explains the evidence. Kaken developed it in Japan as pralmorelin, a test of how well the pituitary and the brain area that controls it are working. A test needs one dose, one blood draw and a study checking it against the standard test. That is exactly what exists: 77 healthy people and 58 patients. It does not need a trial of health results, so none was run. Work to develop it as a treatment in the United States was reported as stopped.
That leaves the long-term use question with nobody to pay for it. A trial of repeated GHRP-2 in healthy adults would need a year, body make-up measures, and a buyer for a product whose patent ran out long ago. The one drug in this family that did get long trials was a different growth hormone booster that works as a pill. Nobody will write that cheque. So the lack of adult treatment data is a money outcome, not a research finding.
The most useful thing in the published file is also what sellers leave out. A GHRP-2 drip raised food intake by about 36% in seven lean men. That is the hunger hormone (ghrelin) receptor doing its job, and it is the opposite of what most buyers want. And the 15 children treated for six months released growth hormone and grew faster, but showed no clear rise in IGF-1. A growth hormone pulse and a tissue-building state are not the same thing.
The evidence, in charts
Fig. 1a · how many people
109people, across 4 studies in people cited here
| Study | People | Share |
|---|---|---|
| European Journal of Endocrinology 2007 | 77 | 71% |
| Journal of Endocrinology 1997 | 15 | 14% |
| Journal of Pediatric Endocrinology and Metabolism 2003 | 10 | 9% |
| Journal of Clinical Endocrinology and Metabolism 2005 | 7 | 6% |
One study holds 71% of these people, so the total rests more on one study than its size suggests. Counts are the number of people each study on this page says it signed up. That includes studies that only watched people and gave nobody the compound. Studies still signing people up are left out, and only studies cited on this page are counted.
Fig. 1b · evidence mix
4 of 5 sources here are studies in people. The rest is not.
- Study in people · done in people480%
- Review of studies · sums up other studies120%
Counted from the list of sources on this page. It counts only what we cite, so there may be more studies out there. A review counts once, however many studies it sums up.
Fig. 2 · evidence over time
The studies cover 5 different years, 1997 to 2007, counted from the list of sources on this page. The newest source on file is from 2007, more than five years ago. Research on it may have gone quiet.
Fig. 3 · legal status at a glance
US
Not approved
UK
Not approved
AU
Not approved
CA
Not approved
Not approved in any of the four countries shown. This is what the law says, not a verdict on the science. See Legal status below for the full text and any notes.
Fig. 4 · how much does what
Nobody has tested different amounts in people
This chart would show how the effect changes as the amount goes up. For this compound, nobody has measured that in people. So we leave it empty. We will not borrow an animal chart and pretend it works the same in people.
Fig. 5 · what the molecule is
- Kind of compound
- Peptide
- Molecule weight
- 817.0 Da
- Half-life
- About 45 minutesUltra-short, minutes
- Chain length
- None on file
No amino acid sequence is on file for GHRP-2, so none is drawn rather than guessed from a name.
The studies we cite
- Study in people2007A simple diagnostic test using GH-releasing peptide-2 in adult GH deficiency
This is a diagnostic test, not a treatment. Seventy-seven healthy people and fifty-eight adults known to be short of growth hormone were each given a single 100 microgram injection into a vein. Growth hormone in the blood was then tracked. A peak below 15 units per litre separated the deficient adults from the healthy ones reliably. That is what GHRP-2 was shown to do here. Nothing in this study says that taking it repeatedly builds muscle, burns fat, or improves anything.
Validation in 77 healthy subjects and 58 GH-deficient patients: a 100 microgram IV GHRP-2 test with a 15 microgram/L peak cut-off reliably identified severe adult GH deficiency.
- Study in people2005Growth hormone releasing peptide-2 (GHRP-2), like ghrelin, increases food intake in healthy men
GHRP-2 makes people eat more. Seven lean men were given it as a drip and then offered food freely. They ate about a third more than they otherwise would, and growth hormone rose sharply at the same time. That appetite push is a real effect of the drug, not a side note. Seven men is a very small group, and they were all lean and healthy. Nobody has tested what repeated dosing does to weight over weeks or months.
A GHRP-2 infusion increased ad libitum intake by about 36% in seven lean men alongside a strong GH rise, so its appetite effect is reduced rather than absent.
- Study in people1997Treatment effects of intranasal growth hormone releasing peptide-2 in children with short stature
Children given GHRP-2 up the nose grew faster, and the study had nothing to compare them against. Fifteen short children took it twice and later three times a day for months. Their growth rate rose from under four centimetres a year to about six. The blood marker usually treated as the sign of a growth hormone effect did not move. Everybody in the study got the peptide, so growing faster cannot be separated from growing older, or from being watched closely.
15 children given 5 to 15 micrograms/kg intranasally twice then three times daily: height velocity rose from 3.7 to 6.1 cm/year at 6 months with no significant change in IGF-1 or IGFBP-3 and no control group. Growth hormone binding protein rose from 439 to 688 pmol/L.
- Study in people2003Changes in appetite and body weight in response to long-term oral administration of the ghrelin agonist GHRP-2 in growth hormone deficient children
Oral GHRP-2 made children hungrier and did not change their build. Ten children with a growth hormone deficiency swallowed it twice a day for a year. Seven of the ten reported a clear rise in appetite in the first six months. Their weight for height barely moved across the year, and the authors report that change as too small to mean anything. There was no comparison group. Appetite is the ghrelin system working as designed, and it is the opposite of what most buyers want.
10 prepubertal children given 900 micrograms/kg orally twice daily for 12 months: 7 of 10 reported increased appetite in the first 6 months, while body mass index standard deviation score moved from 0.21 to 0.25, which was not significant.
- Review of studies2004Pralmorelin: GHRP 2, GPA 748, growth hormone-releasing peptide 2, KP-102 D, KP-102 LN
A profile of the drug's history. Japan's Kaken developed it as a test of the brain's hormone glands. Work to make it a US treatment seemed to have stopped.
Development profile: Kaken's pralmorelin as a diagnostic agent for hypothalamo-pituitary function in Japan; US therapeutic development appeared discontinued.
Where to buy GHRP-2
67 sellers list GHRP-2 in our latest read. They are ranked by trust score, then by archive rating, then by certificate tier, then by the lowest price per milligram. Archive evidence is counted before source-backed. Each path is out of 4, and the two are not added. A higher price does not raise the score. The letter is the certificate chip. 4 of them have a published certificate that names GHRP-2.
Some seller links may pay this site when you buy through them. A payment never changes a seller's tier or rank, and no seller has a say in any page.
| Seller | Trust score | Vial sizes | From, per mg | Certificate for GHRP-2 | Seller link |
|---|---|---|---|---|---|
| National Science Labs | 80 StrongSource-backed 4 of 4. Archive evidence 2 of 4.A | 5 mg, 10 mg, 15 mg | $2.40 | None found for GHRP-2 | View |
| Nationwide Peptides | 80 StrongSource-backed 4 of 4. Archive evidence 2 of 4.A | 5 mg, 10 mg, 15 mg | $2.40 | None found for GHRP-2 | View |
| Alpha Peptides | 80 StrongSource-backed 4 of 4. Archive evidence 2 of 4.A | 5 mg | $2.86 | None found for GHRP-2 | View |
| NexXGeN Peptides | 80 StrongSource-backed 4 of 4. Archive evidence 2 of 4.A | 10 mg | $4.50 | None found for GHRP-2 | View |
| Eros Peptides | 80 StrongSource-backed 3 of 4. Archive evidence 2 of 4.A | 10 mg | $2.60 | None found for GHRP-2 | View |
| Peptide Power US | 77 StrongSource-backed 4 of 4. Archive evidence 2 of 4.A | 5 mg | $8.80 | None found for GHRP-2 | View |
| BioGenix Peptides | 75 StrongSource-backed 4 of 4. Archive evidence 2 of 4.A | 10 mg | $4.80 | None found for GHRP-2 | View |
| General Peptides | 73 StrongSource-backed 4 of 4. Archive evidence 2 of 4.A | 5 mg, 10 mg, 15 mg | $2.40 | None found for GHRP-2 | View |
| Almighty Peptides | 73 StrongSource-backed 4 of 4. Archive evidence 2 of 4.A | 5 mg | $7.20 | None found for GHRP-2 | View |
| Pure Peptide Labs | 70 StrongSource-backed 4 of 4. Archive evidence 2 of 4.A | 5 mg, 10 mg | $5.00 | None found for GHRP-2 | View |
| American Peptide Research | 70 StrongSource-backed 4 of 4. Archive evidence 2 of 4.A | 5 mg | $14.8 | None found for GHRP-2 | View |
| Modern Research Peptides | 67 FairSource-backed 4 of 4. Archive evidence 4 of 4.LC | 10 mg | $3.00 | Lab-confirmed certificate, Freedom Diagnostics | View |
| NuLife Peptides | 67 FairSource-backed 3 of 4. Archive evidence 2 of 4.B | 10 mg | $4.50 | None found for GHRP-2 | View |
| AIO Peptides | 66 FairSource-backed 3 of 4. Archive evidence 1 of 4.B | 5 mg | $6.08 | None found for GHRP-2 | View |
| Limitless Bio-Tech | 52 FairSource-backed 1 of 4. Archive evidence 1 of 4.C | 10 mg | $2.30 | None found for GHRP-2 | View |
| MogLabs | 49 WeakSource-backed 3 of 4. Archive evidence 3 of 4.A | 5 mg | $3.20 | Certificate, Vanguard Laboratory, Freedom Diagnostics, Chromate | View |
| Biotech Peptides | 49 WeakSource-backed 3 of 4. Archive evidence 3 of 4.A | 5 mg, 10 mg | $3.90 | Certificate, MZ Biolabs | View |
| Oasis Labs | 49 WeakSource-backed 3 of 4. Archive evidence 3 of 4.A | 10 mg | $4.70 | Certificate, Bioviridian, BioChex | View |
| Pentech Peptide | 49 WeakSource-backed 3 of 4. Archive evidence 2 of 4.A | 10 mg | $3.10 | None found for GHRP-2 | View |
| Research Purpose Labs | 49 WeakSource-backed 3 of 4. Archive evidence 2 of 4.A | 5 mg | $3.40 | None found for GHRP-2 | View |
| Luxe Peptides | 49 WeakSource-backed 3 of 4. Archive evidence 2 of 4.A | 10 mg | $3.70 | None found for GHRP-2 | View |
| Triantex | 49 WeakSource-backed 3 of 4. Archive evidence 2 of 4.A | 5 mg, 10 mg | $3.80 | None found for GHRP-2 | View |
| Peptify Labs | 49 WeakSource-backed 3 of 4. Archive evidence 2 of 4.A | 10 mg | $4.00 | None found for GHRP-2 | View |
| Vital Core Research | 49 WeakSource-backed 3 of 4. Archive evidence 2 of 4.A | 5 mg, 10 mg | $4.30 | None found for GHRP-2 | View |
| Lifetime Peptides | 49 WeakSource-backed 3 of 4. Archive evidence 2 of 4.A | 10 mg | $4.70 | None found for GHRP-2 | View |
| Elite Edge Biotech | 49 WeakSource-backed 3 of 4. Archive evidence 2 of 4.A | 5 mg | $5.00 | None found for GHRP-2 | View |
| Heartland Bio Labs | 49 WeakSource-backed 3 of 4. Archive evidence 2 of 4.A | 5 mg, 10 mg, 15 mg | $5.67 | None found for GHRP-2 | View |
| Novara Peptides | 49 WeakSource-backed 3 of 4. Archive evidence 2 of 4.A | 10 mg | $6.50 | None found for GHRP-2 | View |
| San Diego Peptides | 49 WeakSource-backed 3 of 4. Archive evidence 2 of 4.A | 5 mg, 10 mg | $7.50 | None found for GHRP-2 | View |
| Peptides Kingdom | 49 WeakSource-backed 3 of 4. Archive evidence 2 of 4.A | 5 mg | $7.80 | None found for GHRP-2 | View |
| World Wide Peptides | 49 WeakSource-backed 3 of 4. Archive evidence 2 of 4.A | 5 mg, 10 mg | $15.1 | None found for GHRP-2 | View |
| Alpha Peps | 49 WeakSource-backed 2 of 4. Archive evidence 2 of 4.B | 10 mg | $3.50 | None found for GHRP-2 | View |
| Apexlab | 49 WeakSource-backed 2 of 4. Archive evidence 2 of 4.B | 5 mg, 10 mg | $3.60 | None found for GHRP-2 | View |
| Behemoth Labz | 49 WeakSource-backed 3 of 4. Archive evidence 1 of 4.B | 10 mg | $4.43 | None found for GHRP-2 | View |
| Pure Peptide Factory | 48 WeakSource-backed 1 of 4. Archive evidence 1 of 4.C | 5 mg, 10 mg, 15 mg | $2.67 | None found for GHRP-2 | View |
| Solution Peptides | 48 WeakSource-backed 1 of 4. Archive evidence 0 of 4.C | 5 mg, 10 mg | $3.80 | None found for GHRP-2 | View |
| Melanotan Express | 46 WeakSource-backed 3 of 4. Archive evidence 1 of 4.B | 5 mg | $4.80 | None found for GHRP-2 | View |
| Top Peptides | 45 WeakSource-backed 2 of 4. Archive evidence 1 of 4.C | 5 mg | $3.60 | None found for GHRP-2 | View |
| Peptide Works | 43 WeakSource-backed 2 of 4. Archive evidence 1 of 4.B | 5 mg, 10 mg | $2.40 | None found for GHRP-2 | View |
| Pryma Lab | 43 WeakSource-backed 1 of 4. Archive evidence 0 of 4.C | 5 mg, 10 mg | $2.10 | None found for GHRP-2 | View |
| Atomik Labz | 43 WeakSource-backed 1 of 4. Archive evidence 0 of 4.C | 10 mg | $3.90 | None found for GHRP-2 | View |
| Peptides.com | 42 WeakSource-backed 2 of 4. Archive evidence 2 of 4.B | 10 mg | $3.00 | None found for GHRP-2 | View |
| Direct SARMS | 40 WeakSource-backed 1 of 4. Archive evidence 1 of 4.C | 5 mg, 10 mg | $2.41 | None found for GHRP-2 | View |
| Oath Research | 40 WeakSource-backed 1 of 4. Archive evidence 1 of 4.C | 5 mg, 10 mg | $5.00 | None found for GHRP-2 | View |
| Peptide Research Hub | 39 WeakSource-backed 2 of 4. Archive evidence 2 of 4.B | 5 mg | $3.24 | None found for GHRP-2 | View |
| Peptide Pros | 39 WeakSource-backed 4 of 4. Archive evidence 1 of 4.B | 5 mg | $4.80 | None found for GHRP-2 | View |
| Legion Peptides | 38 WeakSource-backed 1 of 4. Archive evidence 1 of 4.C | 5 mg, 10 mg | $4.90 | None found for GHRP-2 | View |
| Canlab International | 37 WeakSource-backed 1 of 4. Archive evidence 1 of 4.C | 10 mg | $3.00 | None found for GHRP-2 | View |
| Limitless Biotech ST | 36 WeakSource-backed 1 of 4. Archive evidence 1 of 4.C | 5 mg, 10 mg, 15 mg | $2.40 | None found for GHRP-2 | View |
| Aries Peptide Research | 36 WeakSource-backed 1 of 4. Archive evidence 1 of 4.C | 10 mg | $4.00 | None found for GHRP-2 | View |
| Evolution Peptides USA | 36 WeakSource-backed 1 of 4. Archive evidence 1 of 4.C | 5 mg | $6.00 | None found for GHRP-2 | View |
| Lejian Biotech Peptide | 35 WeakSource-backed 1 of 4. Archive evidence 1 of 4.C | 5 mg | $4.00 | None found for GHRP-2 | View |
| Soma Peptides | 29 InsufficientSource-backed 4 of 4. Archive evidence 1 of 4.Letter withheld | 10 mg | $4.40 | None found for GHRP-2 | View |
| Peptides Sales | 28 InsufficientSource-backed 1 of 4. Archive evidence 1 of 4.C | 5 mg | $4.00 | None found for GHRP-2 | View |
| LabRat Peptides | 28 InsufficientSource-backed 1 of 4. Archive evidence 1 of 4.C | 2 mg | $18.0 | None found for GHRP-2 | View |
| Huaian Hanyou Peptide | 25 InsufficientSource-backed 1 of 4. Archive evidence 1 of 4.C | 5 mg | $4.00 | None found for GHRP-2 | View |
| MJA Peptides | 25 InsufficientSource-backed 1 of 4. Archive evidence 1 of 4.C | 5 mg | $4.00 | None found for GHRP-2 | View |
| ZL Peptides | 25 InsufficientSource-backed 1 of 4. Archive evidence 1 of 4.C | 5 mg | $4.00 | None found for GHRP-2 | View |
| Ascend Peptides | 25 InsufficientSource-backed 1 of 4. Archive evidence 1 of 4.C | 2 mg, 5 mg, 10 mg, 15 mg | $4.53 | None found for GHRP-2 | View |
| Peptide Science LLC | 25 InsufficientSource-backed 1 of 4. Archive evidence 1 of 4.C | 5 mg, 10 mg | $5.00 | None found for GHRP-2 | View |
| USA Peptide Sciences | 25 InsufficientSource-backed 1 of 4. Archive evidence 1 of 4.C | 10 mg | $5.00 | None found for GHRP-2 | View |
| Vantyx Research | 25 InsufficientSource-backed 1 of 4. Archive evidence 1 of 4.C | 5 mg | $7.00 | None found for GHRP-2 | View |
| Pharma Grade Peptides | 25 InsufficientSource-backed 1 of 4. Archive evidence 0 of 4.C | 10 mg | $3.50 | None found for GHRP-2 | View |
| Pure Health Peptides | 25 InsufficientSource-backed 1 of 4. Archive evidence 0 of 4.C | 5 mg | $4.20 | None found for GHRP-2 | View |
| RUO | 18 InsufficientSource-backed 3 of 4. Archive evidence 2 of 4.Letter withheld | 5 mg | $2.80 | None found for GHRP-2 | View |
| Tydes | 15 InsufficientSource-backed 1 of 4. Archive evidence 0 of 4.Letter withheld | 12 mg | $9.17 | None found for GHRP-2 | View |
| Apex Peptides | 0 InsufficientSource-backed 1 of 4. Archive evidence 0 of 4.Letter withheld | 5 mg | $6.60 | None found for GHRP-2 | View |
- LC Lab-confirmed: the issuing laboratory echoed this certificate back
- A Current certificate, independent laboratory named, laboratory not yet checked
- B Certificate published, but no laboratory link, older than a year, or the laboratory did not recognise the published lookup
- C No certificate could be read
Every listing and vial size for GHRP-2 · How the trust score is counted
Sellers named on the price pages are ranked by certificate tier, then price, and any affiliate income is disclosed there. Naming a seller is not a recommendation to buy or use anything.
Common questions
Has GHRP-2 been tested in people?
Yes. 102 people given it across 3 completed trials cited here, 2 of which found nothing. GHRP-2 is a lab-made peptide that makes the body release a strong burst of growth hormone. Japan approves it as a test for growth hormone shortage. It pushes appetite less than GHRP-6, but it still pushes it.
What is the GHRP-2 dosage?
No human dose established. Amounts that circulate in forums and on vendor pages are not a human dose. Amounts that were given in studies sit in Human evidence on this page. Commonly reported amounts, in mcg. No approved label.
Is GHRP-2 FDA-approved?
Not FDA-approved (approved in Japan as a diagnostic agent)
Is GHRP-2 approved anywhere?
It is approved in Japan as a test of how much growth hormone the body makes. It is not approved as a treatment in the US, UK, Australia or Canada.